TABLE 2 .
General characteristics and mean dietary intake of energy, macronutrients, fiber forms, and phyto-compounds in patients with SLE and healthy controls
| Characteristic | SLE patients (n = 20) |
Healthy controls (n = 20) |
|---|---|---|
| Female sex (%) | 100 | 100 |
| Age (yrs) | 49.2 ± 10.7b | 46.9 ± 8.6 |
| BMI (kg/m2) | 26.1 ± 5.3 | 25.2 ± 4.2 |
| Energy (kcal/day) | 2,173.1 ± 722.4 | 1,875.9 ± 332.8 |
| Lipid (g/day)a | 84.5 ± 41.0 | 85.4 ± 20.5 |
| MUFA (g/day)a | 35.3 ± 19.7 | 35.7 ± 7.6 |
| PUFA (g/day)a | 17.2 ± 9.7 | 17.5 ± 9.4 |
| SFA (g/day)a | 24.9 ± 14.1 | 25.0 ± 6.0 |
| Protein (g/day)a | 104.9 ± 27.6 | 100.6 ± 20.9 |
| Carbohydrates (g/day)a | 205.0 ± 75.6 | 203.5 ± 47.0 |
| Dietary fiber (g/day)a | 24.9 ± 10.4 | 25.3 ± 9.1 |
| Insoluble fiber (g/day)a | 16.0 ± 8.6 | 16.6 ± 7.5 |
| Soluble fiber (g/day)a | 2.9 ± 1.5 | 2.8 ± 1.1 |
| Total isoflavones (mg/day)a | 2.4 ± 2.4 | 2.5 ± 2.7 |
| Total phenolics (mg/day)a | 833.2 ± 527.3 | 916.3 ± 437.8 |
a
Model was adjusted for energy and BMI. PUFA, polyunsaturated fatty acids; MUFA, monounsaturated fatty acids; SFA, saturated fatty acids.
b
Values are means ± SD.